A phase 1 study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus [abstract 87] | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

A phase 1 study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus [abstract 87]

Chappell CA, Krans EE, Bunge K, et al. A phase 1 study of ledipasvir/sofosbuvir in pregnant women with hepatitis C virus [abstract 87]. Presented at the Conference on Retroviruses and Opportunistic Infections; March 4-7. 2019.

Publication Type:

Conference Proceedings

Authors:

Chappell, CA; Krans, EE; Bunge, K; et, al

Source:

Presented at the Conference on Retroviruses and Opportunistic Infections; March 4-7 (2019)

Cited On:

Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy

Export Citation:

RIS Format

Top